Sepsis-AMR Panel

Sepsis-AMR panel is an advanced diagnostic test that uses RT-PCR technology to detect various bacteria, fungi, and resistance genes directly from a patient’s blood sample. It checks for 22 bacterial and fungal pathogens and 8 antimicrobial resistance (AMR) genes.

With this comprehensive test, doctors can pinpoint the exact cause of sepsis and understand if the infection is resistant to specific antibiotics. By offering quick and precise results, MedGenome’s sepsis-AMR panel is here to simplify testing for sepsis and improve patient outcomes.

Antimicrobial resistance (AMR) is a significant challenge in treating infections. When bacteria or fungi develop resistance to antibiotics or antifungals, treatment becomes less effective, making infections like sepsis more challenging to manage. Sepsis-AMR panel helps identify these resistance genes, ensuring the use of appropriate medications and reducing unnecessary antibiotic use.

Delayed diagnosis and treatment of sepsis can be catastrophic. As sepsis progresses, it can lead to:

• Multi-organ failure.
• Irreversible tissue damage.
• Higher mortality rates.

In severe cases, each hour of delay in effective treatment raises the risk of death significantly. That’s why testing for sepsis with rapid and accurate methods like the sepsis-AMR panel is vital in managing this emergency effectively.

Sepsis-AMR panel simplifies the diagnostic journey by using whole blood samples. Here’s how it works:

• Sample Collection: A blood sample is taken from the patient.
• RT-PCR Analysis: The sample undergoes real-time PCR testing to detect pathogens and resistance genes.
• Results Interpretation: Within hours, healthcare providers receive detailed insights into the infection, enabling informed decisions.

This streamlined sepsis testing process is particularly beneficial in critical care settings, where every moment matters.

The results of a sepsis panel test can offer vital information:

• Positive for Pathogens: Indicates the specific bacteria or fungi causing the infection and any resistance genes present, guiding targeted treatment.
• Negative Result: Suggests that the pathogens tested were not found, but sepsis cannot be entirely ruled out without further clinical evaluation.

Always discuss your sepsis screening results with your doctor to understand their implications for your health.

At MedGenome, we prioritize accuracy and speed in critical care diagnostics. Here’s why our sepsis-AMR panel stands out:

• Direct Testing from Whole Blood: Simplifies the testing process, saving valuable time in emergencies.
• CE-IVD Certified: It meets strict standards for accuracy and reliability. This certification is a mark of quality, giving patients and doctors confidence in the results.
• Open PCR System: This system offers the flexibility to customise testing according to clinical needs, making it suitable for diverse patient scenarios.

Trust MedGenome for reliable and comprehensive testing for sepsis that empowers doctors and patients alike.